| Dr David Mikhail, MD, FRCSC | |
|
450 Lakeville Rd Ste M41, New Hyde Park, NY 11042-1117 | |
| (516) 734-8567 | |
| (516) 734-8537 |
| Full Name | Dr David Mikhail |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 11 Years |
| Location | 450 Lakeville Rd Ste M41, New Hyde Park, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669959763 | NPI | - | NPPES |
| 2030401 | Other | ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 294259-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elmhurst Hospital Center | Elmhurst, NY | Hospital |
| Queens Hospital Center | Jamaica, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 8224282926 | 250 |
News Archive
A new study suggests that the risk for sleep disorders among college freshmen may be a predictor of retention and academic success.
An encapsulation breakthrough by researchers at the Technion-Israel Institute of Technology may enable doctors to deliver anti-cancer drugs directly to tumors over extended periods of time, while preventing the systemic side effects of chemotherapy and other current cancer treatments.
If you've been to the doctor, you probably know what to do when you're handed a plastic cup and shown to the bathroom. Most patients hand over the sample and give little thought to what happens when it's shipped to the lab for analysis. Ken Marcus and his students are the exceptions. They have developed a new testing method that they believe will reduce costs, get faster results and lower the volume of urine needed for a sample.
Pharmasset, Inc. announced today that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 400mg QD in combination with ribavirin (RBV), with 0, 4, 8, or 12 weeks of pegylated interferon alfa 2a (Peg-IFN) in treatment-naive patients infected with HCV genotype 2 or 3.
Researchers from the University of California, Irvine developed a breakthrough cell therapy to improve memory and prevent seizures in mice following traumatic brain injury.
› Verified 2 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
A new study suggests that the risk for sleep disorders among college freshmen may be a predictor of retention and academic success.
An encapsulation breakthrough by researchers at the Technion-Israel Institute of Technology may enable doctors to deliver anti-cancer drugs directly to tumors over extended periods of time, while preventing the systemic side effects of chemotherapy and other current cancer treatments.
If you've been to the doctor, you probably know what to do when you're handed a plastic cup and shown to the bathroom. Most patients hand over the sample and give little thought to what happens when it's shipped to the lab for analysis. Ken Marcus and his students are the exceptions. They have developed a new testing method that they believe will reduce costs, get faster results and lower the volume of urine needed for a sample.
Pharmasset, Inc. announced today that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 400mg QD in combination with ribavirin (RBV), with 0, 4, 8, or 12 weeks of pegylated interferon alfa 2a (Peg-IFN) in treatment-naive patients infected with HCV genotype 2 or 3.
Researchers from the University of California, Irvine developed a breakthrough cell therapy to improve memory and prevent seizures in mice following traumatic brain injury.
› Verified 2 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609120674 PECOS PAC ID: 8224282926 Enrollment ID: O20130205000439 |
News Archive
A new study suggests that the risk for sleep disorders among college freshmen may be a predictor of retention and academic success.
An encapsulation breakthrough by researchers at the Technion-Israel Institute of Technology may enable doctors to deliver anti-cancer drugs directly to tumors over extended periods of time, while preventing the systemic side effects of chemotherapy and other current cancer treatments.
If you've been to the doctor, you probably know what to do when you're handed a plastic cup and shown to the bathroom. Most patients hand over the sample and give little thought to what happens when it's shipped to the lab for analysis. Ken Marcus and his students are the exceptions. They have developed a new testing method that they believe will reduce costs, get faster results and lower the volume of urine needed for a sample.
Pharmasset, Inc. announced today that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 400mg QD in combination with ribavirin (RBV), with 0, 4, 8, or 12 weeks of pegylated interferon alfa 2a (Peg-IFN) in treatment-naive patients infected with HCV genotype 2 or 3.
Researchers from the University of California, Irvine developed a breakthrough cell therapy to improve memory and prevent seizures in mice following traumatic brain injury.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Mikhail, MD, FRCSC 450 Lakeville Rd Ste M41, New Hyde Park, NY 11042-1117 Ph: (516) 734-8567 | Dr David Mikhail, MD, FRCSC 450 Lakeville Rd Ste M41, New Hyde Park, NY 11042-1117 Ph: (516) 734-8567 |
News Archive
A new study suggests that the risk for sleep disorders among college freshmen may be a predictor of retention and academic success.
An encapsulation breakthrough by researchers at the Technion-Israel Institute of Technology may enable doctors to deliver anti-cancer drugs directly to tumors over extended periods of time, while preventing the systemic side effects of chemotherapy and other current cancer treatments.
If you've been to the doctor, you probably know what to do when you're handed a plastic cup and shown to the bathroom. Most patients hand over the sample and give little thought to what happens when it's shipped to the lab for analysis. Ken Marcus and his students are the exceptions. They have developed a new testing method that they believe will reduce costs, get faster results and lower the volume of urine needed for a sample.
Pharmasset, Inc. announced today that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 400mg QD in combination with ribavirin (RBV), with 0, 4, 8, or 12 weeks of pegylated interferon alfa 2a (Peg-IFN) in treatment-naive patients infected with HCV genotype 2 or 3.
Researchers from the University of California, Irvine developed a breakthrough cell therapy to improve memory and prevent seizures in mice following traumatic brain injury.
› Verified 2 days ago
Zeph Okeke, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-7220 Fax: 718-343-6254 | |
Dr. Robert M Moldwin, Urology Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-7334 | |
Manish A Vira, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-3900 Fax: 718-343-6254 | |
Arthur Smith, MD Urology Medicare: Medicare Enrolled Practice Location: Lijmc - Dept Of Urology, 270-05 76th Avenue, New Hyde Park, NY 11040 Phone: 718-470-7222 | |
Dr. Aaron Justin Krill, MD Urology Medicare: Medicare Enrolled Practice Location: 1999 Marcus Ave Ste M18, Department Of Pediatric Urology, New Hyde Park, NY 11042 Phone: 516-466-6953 Fax: 516-466-5608 | |
Christopher Jonathan Hartman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 450 Lakeville Rd, Suite M41, New Hyde Park, NY 11042 Phone: 516-734-8500 | |
Thomas Robert Williams, MD Urology Medicare: Medicare Enrolled Practice Location: 450 Lakeville Rd Ste M41, New Hyde Park, NY 11042 Phone: 516-734-8500 |